Taro Sakaue

Remarkably high prevalence of small dense low-density lipoprotein in Japanese men with coronary artery disease, irrespective of the presence of diabetes

Shinji Koba, Tsutomu Hirano, Gen Yoshino et al. · Atherosclerosis · 2002 · 69 citations

Metabolic Syndrome, Diabetes Epidemiology, Cardiovascular Epidemiology +14

Prolonged increase of plasma non-esterified fatty acids fully abolishes the stimulatory effect of 24 hours of moderate hyperglycaemia on insulin sensitivity and pancreatic beta-cell function in obese men

Nathalie Leung, Taro Sakaue, André C. Carpentier et al. · Diabetologia · 2004 · 69 citations · Full text

Obesity, Metabolic Syndrome, Prolonged Increase +10

Very low-density lipoprotein-apoprotein CI is increased in diabetic nephropathy: Comparison with apoprotein CIII

Tsutomu Hirano, Taro Sakaue, Asako Misaki et al. · Kidney International · 2003 · 57 citations · Full text

Metabolic Syndrome, Urology, Renal Disease +13

Reactions of direct LDL-cholesterol assays with pure LDL fraction and IDL: comparison of three homogeneous methods

Taro Sakaue, Tsutomu Hirano, Gen Yoshino et al. · Clinica Chimica Acta · 2000 · 50 citations

Lipid Analysis, Oxysterol, Biochemistry +10

Low-Dose Candesartan Cilexetil Prevents Early Kidney Damage in Type 2 Diabetic Patients with Mildly Elevated Blood Pressure.

Satoru Murayama, Tsutomu Hirano, Taro Sakaue et al. · Hypertension Research · 2003 · 29 citations · Full text